+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chondroplasty Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5933944
The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to an increase in sports-related injuries, a preference among patients for non-total joint replacement, advances in postoperative care, enhanced training and expertise among healthcare providers, and a rising incidence of joint disorders.

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the integration of regenerative medicine, a focus on outpatient procedures, the introduction of novel biomaterials, the rise in musculoskeletal disorders, and the expansion of the geriatric population. Major trends in the forecast period include technological integration in rehabilitation, the adoption of arthroscopic techniques, advancements in cartilage repair and regeneration, innovations in surgical tools, and the integration of navigation systems.

The anticipated surge in joint-related disorders stands as a catalyst propelling the expansion of the chondroplasty market in the foreseeable future. These disorders encompass a range of health issues affecting joint functionality, often stemming from excessive joint use or abrupt injuries, such as accidents or sports-related incidents. Chondroplasty serves as a treatment for these joint-related disorders by addressing damaged cartilage within a joint. Recent data published by The Lancet in August 2023 highlighted a rise in the incidence of gout, an inflammatory arthritis impacting joints, in the UK. The diagnoses increased from 1.40 per 1,000 adults in March 2021 to 1.44 per 1,000 adults in March 2022. Furthermore, projections from the Centers for Disease Control and Prevention (CDC) in June 2023 estimate that by 2040, approximately 78.4 million (25.9%) US adults aged 18 years or older may receive doctor-diagnosed arthritis (BRFSS). Hence, the escalating prevalence of joint-related disorders is a driving force behind the chondroplasty market's growth trajectory.

The upswing in knee surgeries is poised to fuel the advancement of the chondroplasty market in the forthcoming period. Knee surgery denotes a surgical intervention targeting the knee joint to address a spectrum of conditions, injuries, or disorders impacting knee functionality. Chondroplasty, a surgical procedure focused on repairing and reshaping damaged cartilage within a joint, finds particular application in knee-related treatments. Notably, data from the National Library of Medicine revealed a substantial 18.3% increase in total hip and knee operations performed at over 1150 facilities in 2022 compared to 2020, totaling 2.4 million procedures. Moreover, projections from the same source in January 2023 indicate a projected surge of 139% in total knee arthroplasty (TKA) by 2040 and a striking 469% surge by 2060. As knee surgeries increase, the demand for chondroplasty is correspondingly boosted, fostering the growth dynamics of the chondroplasty market.

The prospective growth of the chondroplasty market has been hindered by limited reimbursement coverage for chondroplasty procedures. The existing reimbursement policies often impose restrictions on the frequency of chondroplasty treatments a patient can receive, posing challenges, particularly for individuals with recurring or extensive cartilage damage necessitating multiple procedures. Moreover, despite partial coverage, patients often face substantial out-of-pocket expenses, including deductibles, copayments, and coinsurance. These financial burdens may dissuade individuals, especially those facing financial constraints, from pursuing chondroplasty. An article published by the National Library of Medicine in December 2022 reported a concerning trend, a decrease in the average reimbursement rate per CPT code for hip arthroscopy procedures. In 2022, the rate dropped to $899.21, reflecting a notable decrease of $242.24 (21.1%) compared to the inflation-adjusted rate of $1,141.45 in 2011. This limited reimbursement coverage poses a significant obstacle to the expansion of the chondroplasty market.

Key players within the chondroplasty market are actively engaged in developing innovative technologies, such as articular cartilage segmentation tools, to enhance customer service offerings. An articular cartilage segmentation tool is a software application designed to automatically or semi-automatically segment articular cartilage from magnetic resonance imaging (MRI) scans. For example, in July 2021, RSIP Vision, an Israel-based software solution provider, introduced the Articular Cartilage Segmentation Tool. This cutting-edge tool leverages deep learning algorithms to automatically segment cartilage from MRI scans, delivering precise and non-invasive assessments of chondral lesions and cartilage-sparing procedures (such as mosaicplasty, micro-fracture, chondroplasty/osteochondral autograft transfer system, autologous chondrocyte implantation). Physicians utilizing RSIP Vision's module can more accurately evaluate an athlete's cartilage integrity, consequently offering optimal cartilage-sparing treatments. This leads to improved outcomes and shorter recovery times, amplifying the tool's potential to transform patient care within the chondroplasty domain.

In July 2023, Avanos Medical Inc., a prominent US-based company specializing in pain management and chronic care solutions, successfully completed the acquisition of Diros Technology Inc. for a sum totaling $60 million. This strategic acquisition serves to bolster Avanos' standing as a frontrunner in the realm of radiofrequency (RF) technology, expanding its portfolio with a comprehensive range of cutting-edge pain treatment devices. Diros Technology Inc., based in Canada, specializes in crafting radiofrequency devices tailored to address joint disorders such as knee, cervical, and lumbar pain. This acquisition marks a significant step for Avanos, enriching its offerings and solidifying its position within the industry by integrating Diros' expertise and unique devices into its product line.

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc, QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

North America was the largest region in the chondroplasty market in 2023. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the chondroplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The main types of chondroplasty include radiofrequency ablation chondroplasty, abrasion chondroplasty, patellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty targets minor imperfections in knee cartilage to minimize joint deterioration. Various anatomies, such as knee, shoulder, hip, and others, are addressed using tools such as shavers, radiofrequency devices, and arthroscopes. Chondroplasty procedures are performed in settings such as hospitals, orthopedic clinics, academic research institutions, and others.

The chondroplasty market research report is one of a series of new reports that provides chondroplasty market statistics, including chondroplasty industry global market size, regional shares, competitors with a chondroplasty market share, detailed chondroplasty market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. This chondroplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Chondroplasty Market Characteristics3. Chondroplasty Market Trends and Strategies
4. Chondroplasty Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Chondroplasty Market Size and Growth
5.1. Global Chondroplasty Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Chondroplasty Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Chondroplasty Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Chondroplasty Market Segmentation
6.1. Global Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radiofrequency Ablation Chondroplasty
  • Abrasion Chondroplasty
  • Atellar Chondroplasty
  • Meniscal Repair
  • Tissue Removal
  • Other Types
6.2. Global Chondroplasty Market, Segmentation by Anatomy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee
  • Shoulder
  • Hip
  • Other Anatomies
6.3. Global Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shavers
  • Radiofrequency Devices
  • Arthroscope
  • Other Equipments
6.4. Global Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Academic Research
  • Other End Use
7. Chondroplasty Market Regional and Country Analysis
7.1. Global Chondroplasty Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Chondroplasty Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Chondroplasty Market
8.1. Asia-Pacific Chondroplasty Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Chondroplasty Market
9.1. China Chondroplasty Market Overview
9.2. China Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Chondroplasty Market
10.1. India Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Chondroplasty Market
11.1. Japan Chondroplasty Market Overview
11.2. Japan Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Chondroplasty Market
12.1. Australia Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Chondroplasty Market
13.1. Indonesia Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Chondroplasty Market
14.1. South Korea Chondroplasty Market Overview
14.2. South Korea Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Chondroplasty Market
15.1. Western Europe Chondroplasty Market Overview
15.2. Western Europe Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Chondroplasty Market
16.1. UK Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Chondroplasty Market
17.1. Germany Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Chondroplasty Market
18.5. France Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Chondroplasty Market
19.9. Italy Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Chondroplasty Market
20.13. Spain Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Chondroplasty Market
21.1. Eastern Europe Chondroplasty Market Overview
21.2. Eastern Europe Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Chondroplasty Market
22.1. Russia Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Chondroplasty Market
23.1. North America Chondroplasty Market Overview
23.2. North America Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Chondroplasty Market
24.1. USA Chondroplasty Market Overview
24.2. USA Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Chondroplasty Market
25.1. Canada Chondroplasty Market Overview
25.2. Canada Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Chondroplasty Market
26.1. South America Chondroplasty Market Overview
26.2. South America Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Chondroplasty Market
27.1. Brazil Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Chondroplasty Market
28.1. Middle East Chondroplasty Market Overview
28.2. Middle East Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Chondroplasty Market
29.1. Africa Chondroplasty Market Overview
29.2. Africa Chondroplasty Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Chondroplasty Market, Segmentation by Equipment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Chondroplasty Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Chondroplasty Market Competitive Landscape and Company Profiles
30.1. Chondroplasty Market Competitive Landscape
30.2. Chondroplasty Market Company Profiles
30.2.1. Johnson & Johnson
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. F. Hoffmann-La Roche Ltd.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Osiris Therapeutics Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Thermo Fisher Scientific Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Takeda Pharmaceutical Company Limited
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Chondroplasty Market Other Major and Innovative Companies
31.1. Medtronic Public Limited Company
31.2. Stryker Corporation
31.3. Teva Pharmaceutical Industries Ltd.
31.4. B. Braun Melsungen AG
31.5. Zimmer Biomet Holdings Inc.
31.6. Smith & Nephew plc
31.7. Sigma-Aldrich Corporation
31.8. Arthrex Inc.
31.9. Bio-Rad Laboratories Inc
31.10. QIAGEN N.V.
31.11. CONMED Corporation
31.12. Promega Corporation
31.13. Organogenesis Holdings Inc.
31.14. Bioventus LLC
31.15. RTI Surgical Holdings Inc.
32. Global Chondroplasty Market Competitive Benchmarking33. Global Chondroplasty Market Competitive Dashboard34. Key Mergers and Acquisitions in the Chondroplasty Market
35. Chondroplasty Market Future Outlook and Potential Analysis
35.1 Chondroplasty Market in 2028 - Countries Offering Most New Opportunities
35.2 Chondroplasty Market in 2028 - Segments Offering Most New Opportunities
35.3 Chondroplasty Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Chondroplasty Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroplasty market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for chondroplasty? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:
1) By Type: Radiofrequency Ablation Chondroplasty; Abrasion Chondroplasty; Atellar Chondroplasty; Meniscal Repair; Tissue Removal; Other Types
2) By Anatomy: Knee; Shoulder; Hip; Other Anatomies
3) By Equipment: Shavers; Radiofrequency Devices; Arthroscope; Other Equipments
4) By End Use: Hospitals; Orthopedic Clinics; Academic Research; Other End Uses

Key Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Osiris Therapeutics Inc.; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Methodology

Loading
LOADING...